Table 4.
KEGG PATHWAY Analysis of Potential Targets by DAVID6.8 (P<0.05)
| Term | Count | P value |
|---|---|---|
| hsa00910:Nitrogen metabolism | 6 | 1.58E-09 |
| hsa05200:Pathways in cancer | 7 | 0.00147002 |
| hsa05215:Prostate cancer | 4 | 0.002977326 |
| hsa04915:Estrogen signaling pathway | 4 | 0.004154887 |
| hsa04015:Rap1 signaling pathway | 5 | 0.00473551 |
| hsa04270:Vascular smooth muscle contraction | 4 | 0.00662614 |
| hsa05219:Bladder cancer | 3 | 0.00810137 |
| hsa05206:MicroRNAs in cancer | 5 | 0.0138639 |
| hsa04923:Regulation of lipolysis in adipocytes | 3 | 0.014759858 |
| hsa00590:Arachidonic acid metabolism | 3 | 0.017363013 |
| hsa05230:Central carbon metabolism in cancer | 3 | 0.01901226 |
| hsa04020:Calcium signaling pathway | 4 | 0.020926395 |
| hsa05218:Melanoma | 3 | 0.0231066 |
| hsa04151:PI3K-Akt signaling pathway | 5 | 0.025838382 |
| hsa04024:cAMP signaling pathway | 4 | 0.02722417 |
| hsa05205:Proteoglycans in cancer | 4 | 0.027940509 |
| hsa04912:GnRH signaling pathway | 3 | 0.036574443 |